back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-10-16 20:17 Tx date 2024-10-11 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,772
+22,727 vol $1.75 each |
113,640 | |
| Filed 2023-12-13 20:27 Tx date 2023-06-30 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Convertible Notes
38 - Redemption, retraction, cancellation, repurchase
|
$
-$2,000 vol $1.00 each |
$0 | |
| Filed 2023-11-04 11:11 Tx date 2023-11-01 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,955
+36,200 vol $1.38 each |
44,160 | |
| Filed 2023-11-04 11:08 Tx date 2023-07-31 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-23,880 vol |
7,960 | |
| Filed 2023-03-02 19:07 Tx date 2023-02-28 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+21,739 vol |
90,913 | |
| Filed 2022-05-20 13:47 Tx date 2022-05-18 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+36,340 vol |
36,340 | |
| Filed 2022-05-20 13:46 Tx date 2022-05-16 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-04 17:54 Tx date 2021-12-01 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$59,655
+14,170 vol $4.21 each |
69,174 | |
| Filed 2021-10-28 12:45 Tx date 2021-10-25 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$46,068
+10,470 vol $4.40 each |
31,840 | |
| Filed 2021-10-28 12:42 Tx date 2021-10-25 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,390
+1,000 vol $4.39 each |
21,370 | |
| Filed 2021-10-28 12:40 Tx date 2021-10-25 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,001
+3,670 vol $4.36 each |
20,370 | |
| Filed 2021-10-28 08:37 Tx date 2021-10-25 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50,353
+11,470 vol $4.39 each |
28,170 | |
| Filed 2021-10-28 08:37 Tx date 2021-10-25 |
$TH
Theratechnologies Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50,353
+11,470 vol $4.39 each |
||
| Filed 2021-06-02 12:58 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+140,845 vol |
140,845 | |
| Filed 2021-06-01 23:24 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
||
| Filed 2021-06-01 19:59 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
||
| Filed 2021-06-01 19:59 Tx date 2021-05-28 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2021-06-01 19:53 Tx date 2020-09-14 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-15 12:15 Tx date 2021-03-10 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares deferred share unit
56 - Grant of rights
|
$49,999
+263,157 vol $0.19 each |
263,157 | |
| Filed 2021-03-15 12:10 Tx date 2020-09-14 |
$TBP
Tetra Bio-Pharma Inc. |
Weil, Dale
4 - Director of Issuer
Direct Ownership
|
Common Shares deferred share unit
00 - Opening Balance-Initial SEDI Report
|